Literature DB >> 2350207

Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.

W H Kaye1, W Berrettini, H Gwirtsman, D T George.   

Abstract

The related central nervous system peptides neuropeptide Y and peptide YY have been found to be among the most potent endogenous stimulants of feeding behavior. We measured these neuropeptides in cerebrospinal fluid to determine whether they contributed to the pathophysiologic characteristics of anorexia and bulimia nervosa. Cerebrospinal fluid neuropeptide Y concentrations were significantly elevated in underweight anorectic patients and in many of the anorectic patients studied at intervals after weight restoration. These levels normalized in long-term weight-restored anorectic patients who had a return of normal menstrual cycles. Increased neuropeptide Y activity may contribute to several characteristic disturbances in anorexia, including menstrual dysregulation. Cerebrospinal fluid peptide YY concentrations were significantly elevated in normal-weight bulimic patients abstinent from pathological eating behavior for a month compared with themselves when actively bingeing and vomiting or compared with healthy volunteers. Increased peptide YY activity may contribute to a drive to overfeed in normal-weight bulimic patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350207     DOI: 10.1001/archpsyc.1990.01810180048008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  17 in total

1.  Spectral analysis of R-R interval variability by short-term recording in anorexia nervosa.

Authors:  M Casu; V Patrone; M V Gianelli; A Marchegiani; G Ragni; G Murialdo; A Polleri
Journal:  Eat Weight Disord       Date:  2002-09       Impact factor: 4.652

Review 2.  Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.

Authors:  Laura A Berner; Tiffany A Brown; Jason M Lavender; Emily Lopez; Christina E Wierenga; Walter H Kaye
Journal:  Mol Cell Endocrinol       Date:  2018-11-02       Impact factor: 4.102

Review 3.  Is anorexia nervosa a neuropsychological disease?

Authors:  C M Braun; M J Chouinard
Journal:  Neuropsychol Rev       Date:  1992-06       Impact factor: 7.444

Review 4.  Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatment.

Authors:  F Brambilla
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.

Authors:  J P Liu; I J Clarke; J W Funder; D Engler
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 6.  Neurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance.

Authors:  Christopher L Rees; Charise M White; Giorgio A Ascoli
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

7.  Urinary peptide levels in women with eating disorders. A pilot study.

Authors:  M Hellzén; J O Larsson; K L Reichelt; P A Rydelius
Journal:  Eat Weight Disord       Date:  2003-03       Impact factor: 4.652

8.  Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food.

Authors:  S P Kalra; M G Dube; A Sahu; C P Phelps; P S Kalra
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 9.  Eating disorders: the current status of molecular genetic research.

Authors:  Susann Scherag; Johannes Hebebrand; Anke Hinney
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-12-24       Impact factor: 4.785

10.  Regulation of hindbrain Pyy expression by acute food deprivation, prolonged caloric restriction, and weight loss surgery in mice.

Authors:  C Gelegen; K Chandarana; A I Choudhury; H Al-Qassab; I M Evans; E E Irvine; C B Hyde; M Claret; F Andreelli; S E Sloan; A B Leiter; D J Withers; R L Batterham
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-03       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.